康希諾生物(06185.HK)重組帶狀皰疹疫苗啟動I期臨床試驗

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

康希諾生物(06185.HK)重組帶狀皰疹疫苗啟動I期臨床試驗

阿思達克 11-09 00:46

康希諾生物(06185.HK)公布，集團與Vaccitech (UK)合作開發的重組帶狀皰疹疫苗「重組帶狀皰疹疫苗」近日於加拿大正式啟動I期臨床試驗，並完成首例受試者入組。臨床試驗旨在評價其安全性及初步免疫原性。

康希諾生物(06185.HK)

Relevant Stocks

康希諾生物(06185.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

康希諾生物(06185.HK)重組帶狀皰疹疫苗啟動I期臨床試驗

Services

About Us

Agreement Statement